• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于具有生存结局的个体治疗规则的移动学习

M-Learning for Individual Treatment Rule With Survival Outcomes.

作者信息

Zhao Zhizhen, Ni Ai, Xu Xinyi, Donneyong Macarius, Lu Bo

机构信息

Department of Statistics, The Ohio State University, Columbus, Ohio, USA.

Division of Biostatistics, College of Public Health The Ohio State University, Columbus, Ohio, USA.

出版信息

Stat Med. 2025 May;44(10-12):e70093. doi: 10.1002/sim.70093.

DOI:10.1002/sim.70093
PMID:40404180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12097882/
Abstract

Individualized treatment rules (ITRs) tailor treatments to individuals based on their unique characteristics to optimize clinical outcomes and resource allocation. Current approaches use outcome modeling or propensity score weighting to control confounding in complex medical data. To avoid model misspecification and the impact of extreme weights, matched-learning (M-learning) was recently proposed for continuous outcomes. In this paper, we expand the existing M-learning methodology to estimate optimal ITRs under right-censored data, as time-to-event outcomes are common in medical research. We construct matched sets for individuals by comparing observed times and incorporate an inverse probability censoring weight into the value function to handle censored observations. Additionally, we consider a full matching design as a possible alternative to the matching with replacement in M-learning. We demonstrate that the proposed value function is unbiased for the true value function without censoring. To gain insight into the empirical performance, we conduct an extensive simulation study that compares M-learning with two matching designs and a weighed learning approach. Results are evaluated based on winning probabilities and estimated values. The simulation reveals that all methods are generally fine in the absence of unmeasured confounders, and different methods show somewhat different performances under various scenarios. But their performance drops substantially in the presence of unmeasured confounders. Finally, we apply these methods to estimate optimal ITRs for patients with atrial fibrillation (AF) complications from an electronic medical record database, where full matching design shows slightly better performance.

摘要

个体化治疗规则(ITRs)根据个体的独特特征为其量身定制治疗方案,以优化临床结果和资源分配。当前的方法使用结果建模或倾向得分加权来控制复杂医学数据中的混杂因素。为避免模型误设和极端权重的影响,最近针对连续结果提出了匹配学习(M-learning)。在本文中,由于事件发生时间结果在医学研究中很常见,我们扩展了现有的M-learning方法,以估计右删失数据下的最优ITRs。我们通过比较观察到的时间为个体构建匹配集,并将逆概率删失权重纳入价值函数以处理删失观测值。此外,我们考虑完全匹配设计作为M-learning中可重复抽样匹配的一种可能替代方案。我们证明,所提出的价值函数在无删失情况下对真实价值函数是无偏的。为深入了解实证性能,我们进行了一项广泛的模拟研究,将M-learning与两种匹配设计以及一种加权学习方法进行比较。结果根据获胜概率和估计值进行评估。模拟结果表明,在不存在未测量混杂因素的情况下,所有方法通常都表现良好,并且在各种情况下不同方法表现出略有不同的性能。但在存在未测量混杂因素的情况下,它们的性能会大幅下降。最后,我们将这些方法应用于从电子病历数据库中估计房颤(AF)并发症患者的最优ITRs,其中完全匹配设计表现出略好的性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/68a14a25ee19/SIM-44-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/2ae879fcc6b1/SIM-44-0-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/10dba6b3ab3e/SIM-44-0-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/c65248d22b68/SIM-44-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/b17a0edb1cf0/SIM-44-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/6a6639f5c8bb/SIM-44-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/a239805bbc29/SIM-44-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/23ab4556dbfc/SIM-44-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/5c701e52d482/SIM-44-0-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/a65139e60250/SIM-44-0-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/09a20975d90b/SIM-44-0-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/a2b4a114f62f/SIM-44-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/5d91de9d2ab5/SIM-44-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/283c9cecd4ee/SIM-44-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/8bfe9d695347/SIM-44-0-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/d8cf6c06bd3e/SIM-44-0-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/9b74d5e9d65b/SIM-44-0-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/b65ef7f0a84c/SIM-44-0-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/68a14a25ee19/SIM-44-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/2ae879fcc6b1/SIM-44-0-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/10dba6b3ab3e/SIM-44-0-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/c65248d22b68/SIM-44-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/b17a0edb1cf0/SIM-44-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/6a6639f5c8bb/SIM-44-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/a239805bbc29/SIM-44-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/23ab4556dbfc/SIM-44-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/5c701e52d482/SIM-44-0-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/a65139e60250/SIM-44-0-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/09a20975d90b/SIM-44-0-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/a2b4a114f62f/SIM-44-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/5d91de9d2ab5/SIM-44-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/283c9cecd4ee/SIM-44-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/8bfe9d695347/SIM-44-0-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/d8cf6c06bd3e/SIM-44-0-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/9b74d5e9d65b/SIM-44-0-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/b65ef7f0a84c/SIM-44-0-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/12097882/68a14a25ee19/SIM-44-0-g004.jpg

相似文献

1
M-Learning for Individual Treatment Rule With Survival Outcomes.用于具有生存结局的个体治疗规则的移动学习
Stat Med. 2025 May;44(10-12):e70093. doi: 10.1002/sim.70093.
2
Self-matched learning to construct treatment decision rules from electronic health records.基于电子病历的自匹配学习构建治疗决策规则
Stat Med. 2022 Jul 30;41(17):3434-3447. doi: 10.1002/sim.9426. Epub 2022 May 5.
3
Model selection for survival individualized treatment rules using the jackknife estimator.利用刀切估计量进行生存个体化治疗规则的模型选择。
BMC Med Res Methodol. 2022 Dec 22;22(1):328. doi: 10.1186/s12874-022-01811-6.
4
Matched Learning for Optimizing Individualized Treatment Strategies Using Electronic Health Records.利用电子健康记录进行匹配学习以优化个性化治疗策略
J Am Stat Assoc. 2020;115(529):380-392. doi: 10.1080/01621459.2018.1549050. Epub 2019 Apr 23.
5
The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.在估计治疗对生存结局的影响时,存在模型误设情况下治疗权重逆概率法和倾向得分完全匹配法的表现。
Stat Methods Med Res. 2017 Aug;26(4):1654-1670. doi: 10.1177/0962280215584401. Epub 2015 Apr 30.
6
Multicategory matched learning for estimating optimal individualized treatment rules in observational studies with application to a hepatocellular carcinoma study.多类别匹配学习在观察性研究中估计最优个体化治疗规则及其在肝细胞癌研究中的应用
Stat Methods Med Res. 2025 Mar;34(3):508-522. doi: 10.1177/09622802241310328. Epub 2025 Jan 23.
7
Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival.通过优化更长生存时间的调整概率来估计个体化治疗规则。
Stat Methods Med Res. 2024 Sep;33(9):1517-1530. doi: 10.1177/09622802241262525. Epub 2024 Jul 25.
8
Tree based weighted learning for estimating individualized treatment rules with censored data.基于树的加权学习方法用于估计含删失数据的个体化治疗规则
Electron J Stat. 2017;11(2):3927-3953. doi: 10.1214/17-EJS1305. Epub 2017 Oct 18.
9
A matching-based machine learning approach to estimating optimal dynamic treatment regimes with time-to-event outcomes.基于匹配的机器学习方法估计具有生存结局的最优动态治疗方案。
Stat Methods Med Res. 2024 May;33(5):794-806. doi: 10.1177/09622802241236954. Epub 2024 Mar 19.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

本文引用的文献

1
Atrial fibrillation burden: a new outcome predictor and therapeutic target.房颤负担:一个新的预后预测因子和治疗靶点。
Eur Heart J. 2024 Aug 16;45(31):2824-2838. doi: 10.1093/eurheartj/ehae373.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
3
Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial Fibrillation and Frailty: A Systematic Review and Meta-Analysis.
直接口服抗凝剂(DOACs)与华法林在房颤合并虚弱患者中的有效性和安全性:一项系统评价和荟萃分析
Front Cardiovasc Med. 2022 Jun 24;9:907197. doi: 10.3389/fcvm.2022.907197. eCollection 2022.
4
Self-matched learning to construct treatment decision rules from electronic health records.基于电子病历的自匹配学习构建治疗决策规则
Stat Med. 2022 Jul 30;41(17):3434-3447. doi: 10.1002/sim.9426. Epub 2022 May 5.
5
Matched Learning for Optimizing Individualized Treatment Strategies Using Electronic Health Records.利用电子健康记录进行匹配学习以优化个性化治疗策略
J Am Stat Assoc. 2020;115(529):380-392. doi: 10.1080/01621459.2018.1549050. Epub 2019 Apr 23.
6
Prognostic score matching methods for estimating the average effect of a non-reversible binary time-dependent treatment on the survival function.用于估计不可逆二元时间依赖性治疗对生存函数平均效应的预后评分匹配方法。
Lifetime Data Anal. 2020 Jul;26(3):451-470. doi: 10.1007/s10985-019-09485-x. Epub 2019 Oct 1.
7
Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC).英国初级医疗中心血管疾病的发病率和患病率:皇家全科医师学院(RCGP)研究与监测中心(RSC)的一项横断面和随访研究。
BMJ Open. 2018 Aug 20;8(8):e020282. doi: 10.1136/bmjopen-2017-020282.
8
Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.增强型结果加权学习估计最优动态治疗方案。
Stat Med. 2018 Nov 20;37(26):3776-3788. doi: 10.1002/sim.7844. Epub 2018 Jun 5.
9
Doubly robust matching estimators for high dimensional confounding adjustment.用于高维混杂因素调整的双稳健匹配估计量。
Biometrics. 2018 Dec;74(4):1171-1179. doi: 10.1111/biom.12887. Epub 2018 May 11.
10
Precision Medicine: From Science To Value.精准医学:从科学到价值。
Health Aff (Millwood). 2018 May;37(5):694-701. doi: 10.1377/hlthaff.2017.1624.